Jeil Pharma Holdings (XKRX:002620) Other Long-Term Liabilities : ₩42,892 Mil (As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Jeil Pharma Holdings Other Long-Term Liabilities?

Jeil Pharma Holdings's other long-term liabilities for the quarter that ended in Mar. 2024 was ₩42,892 Mil.

Jeil Pharma Holdings's quarterly other long-term liabilities increased from Sep. 2023 (₩41,658 Mil) to Dec. 2023 (₩42,798 Mil) and increased from Dec. 2023 (₩42,798 Mil) to Mar. 2024 (₩42,892 Mil).

Jeil Pharma Holdings's annual other long-term liabilities declined from Dec. 2021 (₩70,419 Mil) to Dec. 2022 (₩67,176 Mil) and declined from Dec. 2022 (₩67,176 Mil) to Dec. 2023 (₩42,798 Mil).

Jeil Pharma Holdings Other Long-Term Liabilities Historical Data

The historical data trend for Jeil Pharma Holdings's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharma Holdings Other Long-Term Liabilities Chart

Jeil Pharma Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Jeil Pharma Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Jeil Pharma Holdings Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Jeil Pharma Holdings Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Jeil Pharma Holdings's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeil Pharma Holdings (XKRX:002620) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

N/A

Address

745-5, Banpo-dong, Seocho-gu, Seoul, KOR, 137-810

Website

https://www.jeilpharm.co.kr

Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Jeil Pharma Holdings (XKRX:002620) Headlines

No Headlines